Login / Signup

Sodium glucose co-transporter 2 inhibitors and cardiovascular event protections: how applicable are clinical trials and observational studies to real-world patients?

Shih-Chieh ShaoYi-Han LinKai-Cheng ChangYuk-Ying ChanMing-Jui HungYea-Huei Kao YangEdward Chia-Cheng Lai
Published in: BMJ open diabetes research & care (2020)
The findings provide clear evidence that results from current studies may be less applicable to real-world patients. Further studies are required to support the concept of real-world cardiovascular event protection through SGLT2i.
Keyphrases
  • end stage renal disease
  • clinical trial
  • newly diagnosed
  • chronic kidney disease
  • ejection fraction
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • placebo controlled